Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • December 1992 (Revised September 1996)
  • Case
  • HBS Case Collection

ImmuLogic Pharmaceutical Corporation (Abridged)

By: Josh Lerner
  • Format:Print
  • | Pages:25
ShareBar

Abstract

ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The rationales for and problems of high-technology start-ups are explored. The challenges posed by "windows" for public offerings are highlighted.

Keywords

Decisions; Initial Public Offering; Entrepreneurship; Going Public; Business Startups; Biotechnology Industry; Pharmaceutical Industry; United States

Citation

Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (Abridged)." Harvard Business School Case 293-087, December 1992. (Revised September 1996.)
  • Educators
  • Purchase

About The Author

Josh Lerner

Entrepreneurial Management
→More Publications

More from the Author

    • 2023
    • Faculty Research

    Learning by Investing: Entrepreneurial Spillovers from Venture Capital

    By: Josh Lerner, Jinlin Li and Tong Liu
    • August 2023
    • Management Science

    Anti-Corruption, Government Subsidies, and Innovation: Evidence from China

    By: Lily Fang, Josh Lerner, Chaopeng Wu and Qi Zhang
    • July 2023
    • Journal of Portfolio Management

    Takahashi-Alexander Revisited: Modeling Private Equity Portfolio Outcomes Using Historical Simulations

    By: Dawson Beutler, Alex Billias, Sam Holt, Josh Lerner and TzuHwan Seet
More from the Author
  • Learning by Investing: Entrepreneurial Spillovers from Venture Capital By: Josh Lerner, Jinlin Li and Tong Liu
  • Anti-Corruption, Government Subsidies, and Innovation: Evidence from China By: Lily Fang, Josh Lerner, Chaopeng Wu and Qi Zhang
  • Takahashi-Alexander Revisited: Modeling Private Equity Portfolio Outcomes Using Historical Simulations By: Dawson Beutler, Alex Billias, Sam Holt, Josh Lerner and TzuHwan Seet
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College